Literature DB >> 10866323

Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region.

B Chen1, L He, V H Savell, J J Jenkins, D M Parham.   

Abstract

Expression of the cyclin-dependent kinase inhibitor p21WAF1 can be up-regulated by activation of signal transducers and activators of transcription (STAT) proteins in response to IFN-gamma. In this study, we examined CpG methylation at the p21WAF1 promoter region in rhabdomyosarcomas (RMSs) using Southern blot analysis with the methylation-sensitive restriction enzyme HpaII. Sis-inducible element (SIE)-1, a STAT-responsive element located upstream of the p21 WAF1 CpG island, was completely methylated at an internal CpG in 13 of 26 (50%) primary RMS tumors and 2 of 5 RMS cell lines. In contrast, all normal tissues examined showed a partial methylation pattern at SIE-1. Complete methylation within SIE-1 strongly correlated with decreased p21WAF1 mRNA expression in RMS. We further studied the effects of SIE-1 hypermethylation on p21WAF1 induction by STAT activation. CpG methylation within SIE-1 significantly inhibited binding of activated STAT1 in electrophoretic mobility shift assays and abrogated STAT-mediated transcription activation in response to IFN-gamma in luciferase reporter gene assays. Activation of STAT1 in response to IFN-gamma resulted in increased p21WAF1 expression and growth suppression in RMS cells containing unmethylated SIE-1 but failed to induce p21WAF1 or growth inhibition in RD and A673 cells, both of which were completely methylated within SIE-1. However, demethylation at SIE-1, induced by a demethylating agent 5-aza-2'-deoxycytidine, reactivated p21WAF1 expression and restored the responsiveness to IFN-gamma in RD cells. Our results indicate a mechanism by which altered DNA methylation in the p21 WAF1 promoter region, by precluding STAT1 binding to SIE-1, directly inhibits the p21WAF1 induction and cell growth regulation through the IFN-gamma/STAT signaling pathway in RMS cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10866323

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

1.  JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.

Authors:  Martha L Slattery; Abbie Lundgreen; Susan A Kadlubar; Kristina L Bondurant; Roger K Wolff
Journal:  Mol Carcinog       Date:  2011-11-28       Impact factor: 4.784

2.  Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group study.

Authors:  Rani E George; Jill M Lahti; Peter C Adamson; Kejin Zhu; David Finkelstein; A Mark Ingle; Joel M Reid; Mark Krailo; Donna Neuberg; Susan M Blaney; Lisa Diller
Journal:  Pediatr Blood Cancer       Date:  2010-10       Impact factor: 3.167

3.  Co-expression of heat shock protein 70 and glucose-regulated protein 94 in human gastric carcinoma cell line BGC-823.

Authors:  Xiao-Ping Wang; Jing Liao; Guo-Zhen Liu; Xing-Cui Wang; Hong-Wei Shang
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

4.  IFN-γ +874 T/A polymorphisms contributes to cervical cancer susceptibility: a meta-analysis.

Authors:  Nannan Liu; Yan Song; Weifeng Shi
Journal:  Int J Clin Exp Med       Date:  2015-03-15

5.  Erythroblast transformation by the friend spleen focus-forming virus is associated with a block in erythropoietin-induced STAT1 phosphorylation and DNA binding and correlates with high expression of the hematopoietic phosphatase SHP-1.

Authors:  Kazuo Nishigaki; Charlotte Hanson; Takashi Ohashi; Angelo Spadaccini; Sandra Ruscetti
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Noncanonical NF-κB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer.

Authors:  Jinpu Yu; Yue Wang; Fang Yan; Peng Zhang; Hui Li; Hua Zhao; Cihui Yan; Fan Yan; Xiubao Ren
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

Review 7.  IFNs-signaling effects on lung cancer: an up-to-date pathways-specific review.

Authors:  Vasiliki Galani; Michalis Kastamoulas; Anna Varouktsi; Evangeli Lampri; Antigoni Mitselou; Dimitrios L Arvanitis
Journal:  Clin Exp Med       Date:  2016-07-14       Impact factor: 3.984

8.  Epigenetic Combination Therapy for Children With Secondary Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML) and Concurrent Solid Tumor Relapse.

Authors:  Chana L Glasser; Alice Lee; Don Eslin; Lianna Marks; Shakeel Modak; Julia L Glade Bender
Journal:  J Pediatr Hematol Oncol       Date:  2017-10       Impact factor: 1.289

9.  Association of mutation and hypermethylation of p21 gene with susceptibility to breast cancer: a study from north India.

Authors:  Naseem Akhter; Md Salman Akhtar; Md Margoob Ahmad; Shafiul Haque; Sarah Siddiqui; Syed Ikramul Hasan; Nootan K Shukla; Syed Akhtar Husain
Journal:  Mol Biol Rep       Date:  2014-01-24       Impact factor: 2.316

10.  S-phase delay in human hepatocellular carcinoma cells induced by overexpression of integrin beta1.

Authors:  Yu-Long Liang; Ting-Wen Lei; Heng Wu; Jian-Min Su; Li-Ying Wang; Qun-Ying Lei; Xi-Liang Zha
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.